In our analysis, Stab2 expression was decreased in tumor tissues in KIRP, LUSC, and BRCA, predicting better OS in KIRP and LUSC but worse OS in BRCA, which indicated that the specific role of Stab2 in different cancers needs to be further investigated. Here, STAB2 is linked to neoplasm.